The aim of this study was to assess neopterin, a marker of and controls, respectively. They also had a greater number of peaks in their serial UNCR measurements than controls interferon gamma (IFN-γ) 187 (135-231), 187 (165-277), 218 (164-517) (21-36), 49 (14-86) and 0 (0-6)% for PP, RR, SP patients
Introduction
Multiple sclerosis is an inflammatory demyelinating disease to act as antigen-presenting cells, sources of proinflammatory cytokines and producers of several potential myelinotoxic of the CNS, characterized pathologically by an inflammatory infiltrate predominantly of macrophages, T and B factors. Their activity is potently enhanced by the presence of gamma interferon (IFN-γ), a major T cell pro-inflammatory lymphocytes, plasma cells and variable degrees of axonal loss and gliosis (Allen, 1991) . The macrophages are not only cytokine known to induce relapses in patients with multiple sclerosis (Panitch et al., 1987) . Neopterin, a product of phagocytic, clearing up myelin debris, but are also thought IFN-γ activated macrophages, is an indirect measure of both with the aim of obtaining equal numbers of male and female subjects of similar age to the patients with multiple sclerosis. the levels of IFN-γ and IFN-γ induced macrophage activity (Huber et al., 1984) . Neopterin's production is also augmented They were only included if they had no underlying medical problems. All patients were recruited from the National by tumour necrosis factor alpha (TNF-α) (Werner-Felmayer et al., 1990) . Neopterin is produced predominantly by cells
Hospital for Neurology and Neurosurgery, London. The study was approved by the hospital's Ethics Committee and written of the monocyte lineage due to a functional block in the pathway synthesizing tetrahydrobiopterin, an essential coinformed consent was obtained from all participants. Subjects were instructed to collect daily specimens of urine, of which factor for the inducible form of nitric oxide synthase (Kwon et al., 1989; Tayeh and Marletta, 1989 ). Neopterin's role as 1-2 ml were placed in small polypropylene tubes, labelled and immediately home frozen in a light-proof container. A a surrogate marker of inflammation has been well studied in infections, particularly HIV, malignancies, autoimmunity, criterion for inclusion in this study was the availability of a home freezer. As the urinary excretion of neopterin shows a especially rheumatoid arthritis and transplantation (Fuchs et al., 1992) . Elevated levels of neopterin have been found diurnal variation, with an~50% fluctuation in baseline levels (Auzéby et al., 1988) , we instructed subjects to collect the in the CSF (Fierz et al., 1987; Fredrickson et al., 1987; Ott et al., 1993; Shaw et al., 1995) and serum (Ott et al., 1993) first specimen passed each day. This period includes the time of peak excretion from 02.00 to 06.00 (Auzéby et al., 1988) , of patients with multiple sclerosis. To date, there are no reports of studies on its longitudinal role as a potential and eliminates any confounding effects of diurnal fluctuations. All specimens from individual subjects were brought to the surrogate marker of disease activity in multiple sclerosis. The need for a reliable and practical surrogate marker laboratory at the end of the study period. In addition to collecting urine, all subjects had to keep a detailed daily of disease activity in multiple sclerosis cannot be overemphasized, as the majority of disease activity in multiple diary throughout the study period. The diary used a fixed format documenting any infections, intercurrent medical sclerosis is asymptomatic (Miller et al., 1988; Koopmans et al., 1989; Willoughby et al., 1989; Capra et al., 1992) . It illnesses, use of corticosteroids or immunosuppressive agents, and comments on changes in neurological function. At the could be argued that MRI is a excellent surrogate marker of inflammation in relapsing patients, but not in patients with end of the study each patient underwent a structured interview to discuss the significance of any entries in the diary; they progressive multiple sclerosis who do not have clinical relapses, and have little, if any, evidence of active inflammaalso had a neurological examination so that physical disability could be rated according to Kurtzke's functional systems and tion on MRI (Thompson et al., 1991) . Neopterin also provides an indication of the role of IFN-γ, a notoriously difficult expanded disability status scale (EDSS) (Kurtzke, 1983) . Finally, on the basis of disease course, patients were classified cytokine to measure in vivo, in the immunopathogenesis of multiple sclerosis.
into one of three groups, as either primary progressive (PP), relapsing remitting (RR) or secondary progressive (SP). The Neopterin, which is relatively stable, is excreted in the urine; dividing its concentration by that of creatinine to diagnostic criteria of these clinical subtypes have been described previously (Thompson et al., 1991) . For the purpose correct for any dilutional effects allows one to assess its production and excretion accurately (Fuchs et al., 1992) . We of this study a clinical relapse was defined as the occurrence of a symptom or symptoms of neurological dysfunction, with therefore performed a study to assess the potential use of serial urinary neopterin to creatinine ratios (UNCRs) as an or without objective confirmation, lasting Ͼ24 h (Poser et al., 1983) . Remission was defined as a definite improvement of immunological marker of disease activity in multiple sclerosis, and to delineate the role of IFN-γ in patients with signs, symptoms, or both, present for periods of ജ 24 h which occurred regularly for ജ1 month (Poser et al., 1983) . multiple sclerosis further. Patients with relapsing as well as progressive multiple sclerosis were studied and compared
The presence of excess urinary nitrites was used as a screen to test for bacterial colonization of the urinary tract. with a group of healthy normal control subjects.
Neopterin and creatinine assays Methods
Urine neopterin and creatinine were measured by HPLC (high pressure liquid chromatography) (Niederweiser et al.,
Subjects
Fourteen normal control subjects and 31 patients with 1982), using a reverse-phase Anasil 80, 5 µm ODS column (Anachem). Elution was performed using degassed clinically definite multiple sclerosis (Poser et al., 1983) were asked to collect consecutive daily urine specimens for periods 15 µmol/l potassium phosphate buffer, pH 6.4, at a flow rate of 1 ml/min. Neopterin detection was by native fluorescence from 2 to 12 weeks in duration. An earlier pilot study, comparing results from 24 h urine collections with those of using an excitation wave length of 353 nm and an emission wavelength of 438 nm. Creatinine was measured using UV spot urine specimens, demonstrated that 24 h collections were too inconvenient and unreliable for such intensive absorption at 235 nm. The fluorescence and UV detector were linked serially to allow the determination of neopterin and monitoring. Normal control subjects were recruited as volunteers from laboratory staff and the general population, creatinine on the same chromatographic run. Urine samples were prepared by diluting them 1:10 with the 15 mmol/l individual variability in neopterin excretion, as this would uncover fluctuations in day-to-day neopterin production that potassium phosphate buffer, pH 6.4, containing 5.4 mmol/l would not necessarily be associated with well defined peaks EDTA (ethylenediaminetetra-acetic acid) to dissolve any in the serial levels or with an elevation in the mean above urinary sediments. A fixed volume sample loop of 20 µl was normal. Thirdly, all peaks in the UNCR versus time curve used. The within-batch, and batch-to-batch, coefficients of were identified and counted. Their identification was achieved variation for the UNCR were 3.9% and 7.6%, respectively, by taking the second derivative of the UNCR time-course using this method. Experiments done in triplicate, on three curve; this derivation was checked visually and if any peaks urine specimens protected from exposure to light showed that were missed by the algorithm, they were manually flagged. the UNCR was stable for 48 h at room temperature, for ജ72 h
The duration of a peak had to be ജ2 days, and its maximum at 4°, and for ജ4 months at -20°C. Exposure of these urine height ജ50% greater than that of the preceding baseline, for specimens to ambient light resulted in a progressive fall in the it to be considered significant. A baseline was defined as a UNCR which became significant after 2 h. Experiments to period of ജ3 days that was not associated with a large study the effect of multiple freeze-thaw cycles on urinary change in the slope, during which all UNCR values were neopterin levels, demonstrated no significant effect on the within 50% of each other. All peaks identified were checked UNCR with up to four freeze-thaw cycles.
with a mathematical algorithm to ensure that they complied with the above definition. Other variables analysed were related to the specific pattern of elevated neopterin excretion,
Data manipulation and statistics
and included the proportion of days on which the UNCRs Due to a smaller muscle mass and lower creatinine excretion, were above normal or whether these elevated levels were females have on average a 20% higher UNCR than males, involved in definite peaks or merely as part of an elevated therefore all UNCRs from female subjects were divided by baseline. a factor of 1.2 to correct for this, thereby allowing direct Data involving serial measurements were computed as comparisons between male and female subjects. This subject means using all readings available for that particular correction factor was obtained empirically, from data subject, after the exclusion of those measurements related to collected on 40 control subjects (data not shown) and infection. The data tended not to be normally distributed in its corresponds exactly to that published in the literature (Fuchs native form and in many cases required a log transformation to et al., 1992).
achieve this aim. If normally distributed before or after In normal subjects, we found that infections can cause an transformation it was compared using a one-way analysis of increase in neopterin production that may precede the onset variance and, if not, the Kruskal-Wallis one-way analysis of symptoms by 24-48 h, therefore all measurements on of variance was used. Between-group comparisons were days of documented infection including the 2 days prior to carried out using the Student's t test, and non-parametric the symptomatic phase of the infection were excluded from data was compared using the Yates corrected χ 2 test, and if the analysis. Due to the nature of this study, infective episodes an expected value was Ͻ5 the Fisher exact test was used. A were not documented objectively, and subjects were given P-value of Ͻ0.05 was considered statistically significant. the benefit of the doubt with regard to their own assessment and interpretation of infection. The UNCRs were then Results processed to generate several variables for each subject. First, the mean of all their UNCRs was used as an overall indicator
Clinical features
of neopterin production. Secondly, the variance of the The clinical data are presented in Table 1 . Ten patients had PP multiple sclerosis, 10 had RR disease and 11 SP disease. individual's UNCRs was used as an indicator of intra- Data are presented as meansϮSD where appropriate. *Differences between the four groups of subjects; † comparing the PP group with all other subjects; ‡ comparing the PP group with the RR and SP groups combined; § comparing the RR group with the PP and SP groups combined. Data are presented as meanϮSD, median (interquartile range), percentages or ratios as appropriate. *P values in the table all refer to comparisons between normal controls and the three patient groups using ANOVA. † All comparisons of normal controls with the individual patient groups are significant (P Ͻ 0.01); ‡ comparison of secondary progressive patients with controls is significant (P ϭ 0.009).
There were significant differences in the sex ratios of the
Urinary neopterin to creatinine ratios
four groups (P ϭ 0.03, Table 1 ). The mean age, calculated Daily urine specimens were collected for~4 weeks in on the final day of urine collection for each subject, differed control subjects and for 7-9 weeks in patients with multiple between groups, with the PP patients being significantly older sclerosis (Table 2) , with a minimum collection period of than the other subjects (P ϭ 0.001, Table 1 ). Similarly, the 14 days. Similar numbers of days were excluded due to mean age of disease onset of the PP patients was significantly infections in all groups (Table 2) . After measurements older than the RR and SP patients (P ϭ 0.006, Table 1 ), related to symptomatic infections were excluded, the which is in accordance with previously published observations subject's mean UNCR over the study period was significantly (Confavreux et al., 1980) . As expected, the disease duration higher in patients with multiple sclerosis than in normal and level of disability were significantly greater in the controls (P Ͻ 0.001, Table 2 and Fig. 1A ). To analyse the progressive multiple sclerosis groups (PP and SP versus pattern of this observed cross-sectional difference we looked RR: P ϭ 0.004 and P Ͻ 0.001 for disease duration and at the other variables relating to the individual UNCR timedisability, respectively, see Table 1 ). Nine clinical relapses course plots described above. First, the natural logarithm of occurred in nine patients during the study period; five in the the variance of the mean UNCR for each subject was greater RR group and four in the SP group. Two of these relapses in patients than in controls (P Ͻ 0.001, Table 2 and were treated with high dose intravenous corticosteroids (1 g Fig. 1B ), which indicates greater day-to-day fluctuations in methylprednisolone intravenously for 3 days). In addition to neopterin excretion or increased variability of the baseline these relapses, two patients in the SP group received of the UNCR time-course plot. Secondly, the proportion of intravenous methylprednisolone, one patient 3 weeks prior days (as a percentage) on which the UNCR was greater than to commencing the study and another patient during the normal, i.e. more than the 'meanϩ2.5ϫSD' of the UNCRs study period. A single patient in the PP group was on low for the normal controls, namely Ͼ198.1 µmol/mol. This dose oral prednisone (10-25 mg/day) throughout the study proportion was significantly elevated in all patient groups period. No other patients received any other immuno-(P Ͻ 0.001, Table 2 and Fig. 1C ). By using a cut-off, with suppressive or immunomodulatory therapy. Twenty nine ജ50% of the serial UNCR measurements above the upper infections occurred in 21 of the 45 subjects during the study.
limit of normal, three out of 10 PP, two out of 10 RR and These all involved the upper respiratory tract except for two five out of 11 SP had elevated baselines, with only the SP urinary tract infections and an episode each of gingivitis, group significantly different from controls (P ϭ 0.009, herpes labialis and a superficial skin infection. When the Table 2 ). numbers of infections occurring in each group were normalIn three out of 14 of the control subjects, three small peaks ized for the duration of the study no significant differences in the serial UNCRs were found in 14 months (424 days) of were noted in the incidence of infection between the study urine testing, that could not be attributed to a symptomatic groups, although the multiple sclerosis patients tended to infection. This contrasted with 143 peaks in 59 months (1759 have fewer infections (Table 1) . Asymptomatic bacterial days) of serial urine testing that were found in all except colonization of the lower urinary tract was detected in two of the 10 PP patients (P Ͻ 0.001). When expressed as four subjects, all of whom were using intermittent selfcatheterization. a rate, the controls had significantly fewer peaks unrelated Combined box and whisker scatter plots for (A) the mean UNCRs, (B) the natural logarithm (log e ) of the variance of the serial UNCRs, (C) the number of peaks per month in the serial UNCR time-course plots unrelated to infection, and (D) the percentage of days with a UNCR greater than normal, for normal control subjects and patients with PP, RR and SP multiple sclerosis. These measurements excluded all UNCRs that were associated with symptomatic infections. The box represents the interquartile range, divided horizontally by the median; the whiskers, the range; and the adjacent scatter plot, the individual values from which the box and whiskers are derived.
to infection than the multiple sclerosis patient groups (P Ͻ the UNCR increased to levels of Ͼ300 µmol/mol that coincided with an upper respiratory tract infection. The 0.001, Table 2 and Fig. 1D) .
Although the SP patients tended to have higher mean patient with SP multiple sclerosis who received intravenous corticosteroids 3 weeks prior to entry into the study, had a UNCRs, greater variability and elevations in their baselines, with more peaks than the PP and RR patients, these persistently elevated UNCR from day 1 of the study and therefore no effects of the corticosteroid treatment on his comparisons did not reach statistical significance (Table 2 and Fig. 1A-D) .
UNCR could be inferred. The other SP patient, who had a severe cerebellar tremor but no evidence of a clinical relapse, received intravenous methylprednisolone when her baseline UNCRs were normal; no effects were noted. Finally, the
Relapses
Five of the nine relapses involved the sensory pathways, patient with PP multiple sclerosis who was on low dose oral prednisone had significantly elevated UNCRs throughout two the brainstem and one each the cerebellum and optic nerve. All patients who had relapses had elevated mean the study. UNCRs. Seven of the relapses were confirmed by clinical examination and two were diagnosed retrospectively on history alone. The median of maximum UNCRs measured
Infections
During the study, 10 infections were recorded by eight control during a relapse was 559 µmol/mol (range 218-13329 µmol/ mol). The median UNCR on the symptomatic days of the subjects, and 19 by 13 patients with multiple sclerosis. To see if infection precipitated relapse or an increase in urinary relapses (215 µmol/mol; interquartile range, 179-358) tended to be higher than the median levels of days not associated neopterin excretion, we analysed the 'at risk period' related to these infectious episodes. This is defined as the 6-week with the relapse in the same patients (160 µmol/mol; interquartile range, 152-189), but was not significant. All period starting 1 week prior to, and ending 5 weeks after, the onset of the infection (Sibley et al., 1985) . As this period patients had increased variability in their baseline UNCRs during the relapse, the median natural logarithm of the includes the episode of infection, a known stimulus for neopterin production, we were unable to use the mean and variance of the UNCR on the symptomatic days of the relapse was 9.7 (range 7.6-16.4); although greater than the variability variance of the UNCR. We therefore analysed the proportion of days associated with an elevated UNCR in relation to the during other periods of the study and greater than variability of the patients without clinical relapse, it did not reach onset of the infection. Not all subjects had a complete set of data points for each infectious episode and in two cases this statistical significance either. Five relapses were time-related with peaks in the baseline, one of which was the highest period had to be modified as a result of a second infection occurring prior to the end of the first 'at risk period' period. detected in the study (Fig. 3, patient SP-4) . These peaks preceded the onset of symptoms in four out of five cases by
In these cases we terminated the first 'at risk period' the day prior to the onset of the second infection and started the next a variable period of time (range 1-14 days). In one case, however, the onset of symptoms preceded the neopterin peak 'at risk period' the following day. We therefore avoided using any data point more than once in the analysis. Eight out of by 5 days. Of the four relapses not associated with a clear peak in the UNCR, three had elevated baselines and one had 13 patients had clearly defined UNCR peaks following on documented infections. This inflammatory activity tended to a single elevated UNCR measurement during the relapse. This latter relapse involved a recurrence of symptoms related persist following on the infection for variable periods of time of up to 6 weeks. In comparison, control subjects had a brisk to a previous brainstem episode with vertigo, dysequilibrium and facial myokymia. No correlation could be found between return to baseline, usually by day 10, from the elevated levels associated with the infectious episode (Fig. 2) . Of note, the clinical severity of the relapses and the levels of elevated neopterin excretion (data not shown).
three of the nine relapses were temporally associated with infections, becoming symptomatic in the 'at risk period' on days 23, 31 and 33 post-infection. Two such examples are given in Fig. 3 , as patients SP-3 and SP-4. Of the four
Corticosteroids
A brainstem relapse associated with a modest increase in the subjects with asymptomatic bacterial colonization of the lower urinary tract, one had a normal baseline with two small UNCR (maximum UNCR ϭ 291 µmol/mol) was treated with high dose intravenous corticosteroids (1 g methylprednisolone peaks, two had elevated baselines with increased variability and one had a normal baseline with intermittent activity that intravenously for 3 days). The UNCR normalized to levels below 100 µmol/mol for a 6-day period, from day 3 of the was associated with a clinical relapse. infusion, but then increased to pre-treatment levels for the remainder of the study. The second patient who received intravenous corticosteroids (for a sensory spinal cord relapse
Individual profiles and frequency of testing
As daily monitoring would be impractical for long term associated with a positive Lhermitte's sign) had a dramatic fall in her UNCR from 1467 to 168 µmol/mol on day 2 of follow-up we compared it with alternate daily and weekly urine sampling frequencies (Table 3) . No differences are the infusion. This response was maintained for 7 days before Fig. 2 Longitudinal serial scatter plot of the proportion of days with a UNCR greater than normal, in relation to the onset of a symptomatic infection, for 10 and 19 infections in eight normal control subjects (triangles) and 13 patients with multiple sclerosis (MS), respectively. The shaded area represents the approximate period related to the infectious episode. Day 0 represents the day of onset of symptoms related to the infection. observed between these different sampling frequencies with of our study was to investigate whether urinary neopterin excretion would be sensitive enough to detect inflammation regard to the cross-sectional data analysis, except the degree of variability in the baseline is reduced with fewer samples.
Table 3 Comparison of the urinary neopterin:creatinine ratio (UNCR) data for daily, alternate day and weekly sampling
in multiple sclerosis and to see if it had any potential as a surrogate inflammatory marker. We chose to study urinary However, the detailed time course and peak analysis becomes more difficult with smaller numbers of samples as some neopterin, because urine is more suitable for frequent selfcollection, home freezing and storage, and the intensive daily peaks are short lived and may be missed by infrequent sampling. Daily serial individual UNCR profiles of three monitoring used in this study would not have been possible with plasma or CSF. Neopterin is excreted in the urine in a control subjects and 10 patients with brief case histories are shown in Fig. 3 . They illustrate the different patterns of concentration several hundred fold higher than that which is found in plasma or CSF, making it easier to detect significant elevated UNCR found in patients with multiple sclerosis, and demonstrate the effects of clinical relapses and infections changes in production (Fuchs et al., 1992) . The kidneys therefore act as an integrator of neopterin production, and on the UNCR time-course plot.
provide more reliable information than the brief snapshot obtained from a plasma or CSF level. In addition, the extended collection periods used in this study allow an
Discussion
Neopterin is a well established marker of cell mediated accurate intra-subject assessment of the day-to-day variability in levels of neopterin excretion. inflammation and preliminary studies have already shown elevated levels in both the CSF and serum of patients with As a result of confounding factors, the raw UNCR data had to be manipulated prior to analysis. First, women who multiple sclerosis (Fierz et al., 1987; Fredrickson et al., 1987; Ott et al., 1993; Shaw et al., 1995) . The primary aim have a lower muscle mass and therefore a lower creatinine excretion and higher UNCRs than men, had their UNCRs correction was made for the higher UNCR that occurs in females and following this, no differences were found reduced by a correction factor to allow a direct comparison with male subjects. This correction factor only affected the between male and female control subjects (data not shown).
As patients and controls were not randomly selected or agemean UNCR levels and did not have any significant effect on the variability of the UNCR or the detection of peaks in and sex-matched, other unidentified confounding variables may be present. the time-course plot. Analysis of the mean UNCR prior to this correction produced similar results. This correction was Neopterin excretion was clearly raised in the majority of our patients, particularly in those with SP multiple sclerosis, performed to minimize any bias due to differences in the sex ratio between the patient groups which would have raised who tended to have the highest levels, followed by the patients with RR and PP disease. This inflammatory hierarchy, the mean levels in the RR and SP groups compared with patients with PP disease. Secondly, the sensitivity gained between the different patient subgroups, corresponds approximately to the one found using gadolinium-enhanced from monitoring urinary neopterin excretion is offset by its lack of specificity, especially as common viral infections give T 1 -weighted MRI as the surrogate marker of CNS inflammation (Thompson et al., 1991 (Thompson et al., , 1992 . In addition, rise to increased urinary neopterin excretion. We therefore excluded UNCR measurements associated with symptomatic clinical activity in the form of a relapse was, without exception, associated with some elevation in neopterin infections. These infections were reported by the subjects in the study and were not confirmed clinically or by laboratory excretion, albeit modest in some cases. Neopterin excretion tended to be higher during clinical relapse, implying that investigations. The reliability of the self-reporting of common viral infections has not been tested, and is therefore unknown.
detection of inflammation with UNCRs is more likely during a relapse than during clinical remission. This has been If any under-reporting of infections occurred in the patient groups compared with control subjects, it would bias the demonstrated by MRI studies which show that the majority of patients in relapse (80%), compared with~25% of patients results. Thirdly, we manipulated the UNCR time-course plot by taking the second derivative to identify any peaks in in remission have detectable gadolinium-enhancement (Thompson et al., 1991 (Thompson et al., , 1992 . Due to the small number of the excretion of urinary neopterin. This is a mathematical technique which recognizes large changes in the slope of the relapses which occurred during this study, it was not possible to assess the association between the level of neopterin UNCR time-course plot and hence identifies peaks. Although this manipulation was effective and reproducible, it excretion and the severity of clinical relapse, or whether increases in neopterin excretion can predict the onset of a occasionally failed to detect peaks that were obvious to the naked eye when many fluctuations were present in the clinical relapse. An important thing to consider is that the clinical severity of a relapse may not relate to the size of the baseline, i.e. when a peak occurred on a noisy baseline. All peaks were checked mathematically to ensure compliance offending lesion, or to its inflammatory mass, but rather to its location in sites which may or may not be clinically with the definition. The mathematical manipulations were entirely reproducible. The reproducibility of the manual eloquent. Therefore, the level of neopterin excretion, and indeed other inflammatory markers, may bear no relation to flagging technique was not assessed. However, this is unlikely to affect the results of the study as the automated detection the severity of a clinical relapse. Although two relapses were not confirmed clinically, we felt confident with a retrospective of peaks only failed in subjects with a noisy baseline which tended to occur in the patients and not the normal controls. diagnosis, as self-reported neurological dysfunction correlates well with that of a formal neurological assessment (VerdierTherefore the manual inspection would have been more likely to miss peaks in the patients, resulting in an underestimation Taillefer et al., 1994) . Asymptomatic elevations in neopterin excretion in the of the differences noted between normal controls and patients with multiple sclerosis.
form of a persistently elevated baseline with or without superimposed peaks, or a normal baseline with intermittent Patient groups could not be age-or sex-matched as PP multiple sclerosis is more common in males than in females, peaks was common in patients with multiple sclerosis, supporting the MRI data that much of the disease activity in and has greater age of disease onset (Confavreux et al., 1980; Compston, 1991) . The differences between the ages and multiple sclerosis is asymptomatic (Miller et al., 1988; Koopmans et al., 1989; Willoughby et al., 1989; Capra et al. , sex ratios of the groups could, however, have possible confounding effects. First, the UNCR is~20% higher in 1992). Two PP patients who had been clinically stable for several years had normal neopterin excretion, suggesting that subjects over the age of 65 years (Fuchs et al., 1992) , but as only one subject in our study was older than 65 years, there was no inflammatory component to their disease process during the study period. Finding elevated levels of neopterin this would be unlikely to affect the results. Secondly, a excretion in some patients with PP multiple sclerosis, 1988; Cannella and Raine, 1995) , and the administration of IFN-γ to patients with multiple sclerosis significantly indicates that ongoing inflammation is occurring in these patients and supports a recent pathological study increased the number of clinical exacerbations (Panitch et al., 1987) . Since infections, particularly viral, result in increased demonstrating low grade inflammation in this subgroup of patients (Revesz et al., 1994) . The fact that inflammatory IFN-γ and neopterin production (Wachter et al., 1992) , could the elevated levels that we detected have been due to activity can be detected by measuring urinary neopterin is very important, as neopterin may provide a means of monitoring subclinical or low grade chronic infections? We feel that this is unlikely for several reasons (unless multiple sclerosis is inflammation in these progressive patients who characteristically lack MRI activity (Thompson et al., 1991;  caused by an unidentified viral infection). First, in normal controls only three peaks in 14 months of daily urine testing Kidd et al., 1996) . However, a caveat to be kept in mind is that the pathogenesis of progressive disability in multiple could not be accounted for by a symptomatic infection. Secondly, the number of subclinical infections would have sclerosis is uncertain; several lines of evidence suggest that it may be due to progressive axonal loss (Arnold et al., 1994;  had to have been very frequent (2-3 per month) and thirdly, patients were instructed to document all ailments, however Davie et al., 1994; Filippi et al., 1994; Lassmann et al., 1994) , but whether this is a consequence of persistent, low minor, and were always given the benefit of the doubt with regard to their interpretation of an infection. Fourthly, after grade inflammation is currently unknown. Although our study was not powered to investigate the association between excluding urinary tract infections, there is no evidence that patients with multiple sclerosis are more predisposed to inflammatory activity and disability, the patients with rapidly progressing disability appeared to have higher and more infection than normal controls. On the contrary, patients with multiple sclerosis have been documented to have significantly persistently elevated levels of neopterin excretion compared with clinically stable patients. Further studies are needed to fewer viral infections than healthy subjects (Sibley et al., 1985) , a trend noted in our study (Table 1) . Finally, neopterin ascertain the relationship between neopterin levels, clinical course and putative MRI markers for axonal loss. Importantly, levels are higher in the CSF than in the serum of patients with multiple sclerosis, a finding opposite to that in nonurinary neopterin excretion appears to be sensitive enough to detect relatively small volumes of inflammation of the inflammatory control patients (Shaw et al., 1995) . This indicates that neopterin is synthesized intrathecally, which order of magnitude of that occurring in multiple sclerosis.
Although only a few patients received high dose intrawould be incompatible with a non-CNS infection causing the increase in neopterin production. Taking these points venous corticosteroids, it appears that this form of treatment suppresses the production of neopterin for a short period of together, we feel that the increase in urinary neopterin excretion is due to inflammatory activity within the CNS. time. This is similar to the transient suppression of gadolinium-enhancement (Ͻ1 week) seen after high dose intravenous
We are currently setting up clinical experiments to assess the relative contributions of the CNS and systemic compartment methylprednisolone (Miller et al., 1992) , and to that which occurs in renal and bone marrow transplant rejection, where to the increased neopterin production observed in patients with multiple sclerosis. the administration of high dose methylprednisolone exerts a dramatic suppression of neopterin production (Wachter et al., The observation that infection is associated with clinical relapse in patients with multiple sclerosis has been known 1992). However, the transplant scenario, in which neopterin excretion is used to monitor immunosuppressive therapy, is for several years (Sibley et al., 1985; Andersen et al., 1991; Panitch, 1994) . We have confirmed this and have confounded by the persistent use of other immunomodulatory drugs that, if successful, cause a sustained suppression demonstrated that this effect is not limited to symptomatic relapses. A third of the relapses in this study occurred in the of neopterin excretion. The effects of high dose corticosteroids and other immunomodulatory therapy on the time course of 'at risk' period and 62% of subjects had a persistent increase in neopterin excretion post-infection for a period much longer neopterin excretion in patients with multiple sclerosis requires assessment. Unfortunately, neopterin may be unsuitable for than expected (Fig. 2) . From this data, it appears infections are a potent stimulus for causing prolonged elevations in monitoring the effects of the type I IFNs (α and β) which are currently in clinical use. They have overlapping actions neopterin excretion beyond the time period expected for an uncomplicated infection. This elevation in neopterin with those of IFN-γ, and cause a non-specific increase in neopterin production by monocytes and macrophages (Chiang production, which occurs for up to and possibly beyond 6 weeks post-infection, is presumably due to an increase or et Liberati et al., 1994) .
Neopterin is a sensitive marker of IFN-γ induced monocyte/ precipitation of both symptomatic and asymptomatic disease activity. As this was not seen in the control subjects it macrophage activity, and T cells that produce the IFN-γ are strongly implicated in the immunopathogenesis of multiple suggests a phenomenon related to disease activity. How infections precipitate disease activity is unknown, but it may sclerosis. Prior to clinical relapses, mitogen-stimulated peripheral blood cells of patients with multiple sclerosis result from the systemic induction of IFN-γ. Our data also suggests that the at risk period may be longer than that produce greater quantities of IFN-γ (Beck et al., 1988) . IFN-γ production has also been demonstrated in actively defined in the literature (Sibley et al., 1985) . Our study demonstrates the informative nature of daily inflamed multiple sclerosis plaques (Traugott and Lebon, Neurol 1992; 49: 687-9 UNCR measurements, which we feel would be impractical Compston DAS. Genetic susceptibility to multiple sclerosis. In:
and unnecessary for a long-term study. A comparative analysis Matthews WB, Compston A, Allen IV, Martyn CN, editors. demonstrates that alternate day and weekly sampling is McAlpine's multiple sclerosis. 2nd ed. Edinburgh: Churchill sufficient to detect inter-group differences, but a sampling Livingstone, 1991: 301-19. frequency of less than this would miss some of the short WI. Use of magnetic resonance spectroscopy to investigate disability
In conclusion, neopterin is a novel, sensitive marker for in multiple sclerosis [abstract] . Ann Neurol 1994; 36: 301. the in vivo production of IFN-γ and other pro-inflammatory cytokines in multiple sclerosis. We believe neopterin is a immune-modulating therapy. However, to be a useful surrogate marker of disease activity, it needs to be shown duration and an EDSS of 6.0. She had a persistently elevated baseline with numerous peaks and a symptomatic spinal cord duration and a EDSS of 6.0. She had the highest elevation in neopterin excretion throughout the study period. Although she did relapse, with sensory symptoms and an associated Lhermitte's sign. Her relapse and increased neopterin excretion was probably not have any neurological symptoms that could be classified as a relapse, she complained of numerous intermittent symptoms, marked precipitated by the preceding viral infection of the upper respiratory tract. day-to-day fluctuations in activities of daily living and severe fatigue. Her disability, however, had not changed in the preceding SP-4. A 46-year-old female with SP multiple sclerosis of 21 years duration, an EDSS of 6.5 and a peak in her UNCR associated with 12 months. SP-3. A 35-year-old female with SP multiple sclerosis of 16 years a mild episode of optic neuritis.
